
GENEXPLAIN GMBH
Grant-FundedCORDISTargeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy
AI / ML · Biotech · SaaS
GENEXPLAIN GMBH is a private SME recorded in CORDIS in Germany, with participation in 12 EU research and innovation projects. Its recorded projects include “Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
EU Grants€4,542,010
All-time revenue—
MRRPrivate••••••
Founder—
Founded—
🇩🇪Germany
RevenuePrivate
Revenue data is privateThis company has chosen not to share revenue metrics
Startup insights
Value proposition
GENEXPLAIN GMBH is a private SME recorded in CORDIS in Germany, with participation in 12 EU research and innovation projects. Its recorded projects include “Targeting tumour-host interactions in paediatric malignant gliomas to reinvigorate immunity and improve radio- and immunotherapy efficacy”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
AI / MLBiotechSaaS
Tags:AI / MLBiotechSaaS
Company Info
GENEXPLAIN GMBH Info
Funding
EU Grants€4,542,010
